Abstract
Thousands of snake bite envenomation’s require treatment in the United States each year. The mainstay of therapy has been an initial dose of antivenom followed by maintenance dosing over the next 24 hours. However, there is little evidence to support maintenance dosing and each vile of antivenom poses a significant financial burden.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.